Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Findings From the EXTEND-DAPT Study

被引：10
|
作者：
Faridi, Kamil F. [1 ,2 ]
Tamez, Hector [2 ]
Strom, Jordan B. [2 ]
Song, Yang [4 ]
Butala, Neel M. [3 ]
Shen, Changyu [2 ]
Secemsky, Eric A. [2 ]
Mauri, Laura [4 ,5 ]
Curtis, Jeptha P. [1 ]
Gibson, C. Michael [2 ,4 ]
Yeh, Robert W. [2 ,3 ,4 ]
机构：
[1] Yale Sch Med, Sect Cardiovasc Med, Dept Med, New Haven, CT USA
[2] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Boston, MA 02215 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA 02115 USA
[4] Baim Inst Clin Res, Boston, MA USA
[5] Medtronic, Minneapolis, MN USA
来源：
CIRCULATION | 2020年 / 142卷 / 03期
关键词：
administrative claims; healthcare; clinical trial; coronary artery disease;
D O I：
10.1161/CIRCULATIONAHA.120.047729
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：306 / 308
页数：3
相关论文
共 50 条
  • [21] Abbreviated Dual Antiplatelet Therapy Followed by P2Y12Inhibitor Monotherapy versus 12 Months' Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Kumar, Ashish
    Shariff, Mariam
    Doshi, Rajkumar
    Vaz, Igor Pedreira
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (04) : 355 - 361
  • [22] Abbreviated Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy versus 12 Months’ Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ashish Kumar
    Mariam Shariff
    Rajkumar Doshi
    Igor Pedreira Vaz
    American Journal of Cardiovascular Drugs, 2020, 20 : 355 - 361
  • [23] Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
    Mauri, Laura
    Kereiakes, Dean J.
    Normand, Sharon-Lise T.
    Wiviott, Stephen D.
    Cohen, David J.
    Holmes, David R.
    Bangalore, Sripal
    Cutlip, Donald E.
    Pencina, Michael
    Massaro, Joseph M.
    AMERICAN HEART JOURNAL, 2010, 160 (06) : 1035 - U70
  • [24] Current Status of Long-Term Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention in Japan: Findings From the National Database
    Kanaoka, Koshiro
    Terasaki, Satoshi
    Nishioka, Yuichi
    Kubo, Shinichiro
    Myojin, Tomoya
    Soeda, Tsunenari
    Noda, Tatsuya
    Watanabe, Makoto
    Kawakami, Rika
    Imamura, Tomoaki
    Saito, Yoshihiko
    CIRCULATION, 2019, 140
  • [25] Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Shetty, Suchith S.
    Aronow, Wilbert S.
    Cooper, Howard A.
    Panza, Julio A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 127 : 25 - 29
  • [26] Effects of long-term proton pump inhibitor use in those receiving dual antiplatelet therapy after percutaneous coronary intervention.
    Nickleson, Jennee
    Bland, Penelope
    Rogers, Kelly C.
    Finks, Shannon W.
    PHARMACOTHERAPY, 2015, 35 (05): : E85 - E85
  • [27] Does Age Have a Differential Effect on 1 Month Versus 3 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk?
    Elkaryoni, Ahmed
    Garg, Aakash
    Abbott, J. Dawn
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 215 : 96 - 97
  • [28] The Author's Response: Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients
    Kim, Dong-Yeon
    Hahn, Joo-Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (22)
  • [29] Impact of >12-Month Versus ≤12-Month Dual Antiplatelet Therapy on Long-Term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention
    Jiang, Yao
    Zhang, Han
    Zhang, Chujie
    Geng, Yingyang
    Zhang, Yin
    Guan, Changdong
    Song, Lei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B114 - B115
  • [30] P2Y12 Inhibitor Monotherapy After a Short Dual Antiplatelet Therapy Versus Standard-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Meta-Analysis
    Ai-Chen Ho
    Ugochukwu Egolum
    Shanea Parker
    Jordan Dimmel
    Andrew Hawkins
    Hua Ling
    Clinical Drug Investigation, 2020, 40 : 799 - 808
12345